These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12173980)

  • 21. N-valproyl-L-phenylalanine as new potential antiepileptic drug: synthesis, characterization and in vitro studies on stability, toxicity and anticonvulsant efficacy.
    De Caro V; Scaturro AL; Sutera FM; Avellone G; Schiera G; Ferrantelli E; Carafa M; Rizzo V; Carletti F; Sardo P; Giannola LI
    Med Chem; 2014; 11(1):30-40. PubMed ID: 24813685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium Valproate Ameliorates Neuronal Apoptosis in a Kainic Acid Model of Epilepsy via Enhancing PKC-Dependent GABA
    Li Q; Li QQ; Jia JN; Cao S; Wang ZB; Wang X; Luo C; Zhou HH; Liu ZQ; Mao XY
    Neurochem Res; 2018 Dec; 43(12):2343-2352. PubMed ID: 30311181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells.
    Taubøll E; Gregoraszczuk EL; Tworzydø A; Wójtowicz AK; Ropstad E
    Epilepsia; 2006 Sep; 47(9):1580-3. PubMed ID: 16981877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
    Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM
    Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teratogenicity of valproate conjugates with anticonvulsant activity in mice.
    Spiegelstein O; Chatterjie N; Alexander G; Finnell RH
    Epilepsy Res; 2003 Dec; 57(2-3):145-52. PubMed ID: 15013055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of action of valproate: a commentatory.
    Johannessen CU
    Neurochem Int; 2000; 37(2-3):103-10. PubMed ID: 10812195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproate teratogenicity and epilepsy syndrome.
    Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
    Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment.
    Sgobio C; Ghiglieri V; Costa C; Bagetta V; Siliquini S; Barone I; Di Filippo M; Gardoni F; Gundelfinger ED; Di Luca M; Picconi B; Calabresi P
    Biol Psychiatry; 2010 Mar; 67(6):567-74. PubMed ID: 20074705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
    Eikel D; Lampen A; Nau H
    Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auditory event related potentials in patients with epilepsy on sodium valproate monotherapy.
    Panagopoulos GR; Thomaides T; Tagaris G; Karageorgiou CL
    Acta Neurol Scand; 1997 Jul; 96(1):62-4. PubMed ID: 9262135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lessons learned from the discovery of sodium valproate and what has this meant to future drug discovery efforts?
    Janković SM; Janković SV
    Expert Opin Drug Discov; 2020 Nov; 15(11):1355-1364. PubMed ID: 32686964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
    Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiepileptic teratogen valproic acid (VPA) modulates organisation and dynamics of the actin cytoskeleton.
    Walmod PS; Skladchikova G; Kawa A; Berezin V; Bock E
    Cell Motil Cytoskeleton; 1999; 42(3):241-55. PubMed ID: 10098937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproate decreases inositol biosynthesis.
    Shaltiel G; Shamir A; Shapiro J; Ding D; Dalton E; Bialer M; Harwood AJ; Belmaker RH; Greenberg ML; Agam G
    Biol Psychiatry; 2004 Dec; 56(11):868-74. PubMed ID: 15576064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition.
    Shah RD; Jagtap JC; Mruthyunjaya S; Shelke GV; Pujari R; Das G; Shastry P
    J Cell Biochem; 2013 Apr; 114(4):854-63. PubMed ID: 23097134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives.
    Eyal S; Yagen B; Shimshoni J; Bialer M
    Biochem Pharmacol; 2005 May; 69(10):1501-8. PubMed ID: 15857614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental studies and controlled clinical testing of valproate and vigabatrin.
    Gram L
    Acta Neurol Scand; 1988 Oct; 78(4):241-70. PubMed ID: 3146860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.
    Semmes RL; Shen DD
    Epilepsia; 1991; 32(2):232-41. PubMed ID: 2004628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular approaches to developmental malformations using analogous forms of valproic acid.
    Okada A; Fujiwara M
    Congenit Anom (Kyoto); 2006 Jun; 46(2):68-75. PubMed ID: 16732764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does Valproic Acid/Na Valproate Suppress Auditory Startle Reflex in Patients With Epilepsy?
    Kızıltan ME; Leba LK; Gündüz A; Pazarcı N; Özkara Ç; Yeni N
    Clin EEG Neurosci; 2018 Nov; 49(6):407-413. PubMed ID: 29262725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.